← Back to Search

Behavioural Intervention

Tele-Palliative Care for Graft-versus-Host Disease (cGVHDTele-PC Trial)

N/A
Waitlist Available
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Patients who have already consulted or are currently consulting palliative care
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 12
Awards & highlights
No Placebo-Only Group

Summary

This trial is looking at whether using telehealth for palliative care is a practical and acceptable option for patients with moderate to severe chronic graft-versus-host disease.

Who is the study for?
This trial is for adults over 18 with moderate to severe chronic graft-versus-host disease (cGVHD) as assessed by their oncologist. Participants must understand and speak English well enough to answer questions. Those with acute psychiatric or cognitive conditions, or who are already in palliative care, cannot join.
What is being tested?
The study is testing the use of telehealth for providing palliative care to patients suffering from cGVHD. It aims to determine how practical and acceptable it is for patients to receive this type of remote healthcare service.
What are the potential side effects?
Since the intervention involves tele-palliative care visits rather than medication, traditional side effects are not expected. However, participants may experience emotional discomfort discussing their condition remotely.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am currently receiving or have received palliative care.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 12
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 12 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Feasibility of the tele-palliative care intervention as measured by the proportion of eligible patients who are approached and agree to participate
Feasibility of the tele-palliative care intervention as measured by the proportion of enrolled participants who complete at least two of the three intervention visits
Secondary study objectives
Acceptability of the tele-palliative care intervention as measured by the Client Satisfaction Questionnaire

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Tele-PC InterventionExperimental Treatment1 Intervention
Participants (individuals with moderate to severe chronic Graft-versus-Host Disease) will receive a monthly at home consultation with a specialty palliative care clinician via a video-conference tele-health visit.

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
3,000 Previous Clinical Trials
13,308,536 Total Patients Enrolled
~7 spots leftby Mar 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top